top of page
PureFlowCath Catheter
The Company is developing PureFlowCath Catheter, the first urinary catheter system to provide continuous irrigation (CSCI) with the objective of reducing urinary tract infections .
Capital provided to date US$ 8.35 million
Patents awarded including EU
Patents securitised in Luxembourg
Prospectus for admission to Toronto Stock
Exchange Venture advanced
The Company following it's regulated listing on a designated stock exchange will enter into new inovative medical device opportunities.
Providing funding and support to medical practitioner's to advance new medical device innovations to market.
bottom of page